https://www.selleckchem.com/pr....oducts/lonafarnib-sc
69; 95% CI 0.65-0.73), 43% (HR, 0.57; 95% CI 0.53-0.6, and 52% (HR, 0.48; 95% CI 0.42-0.56) lower risks of SLD, respectively. For both BMI and nonalcoholic fatty liver disease variants, participants with fewer metabolic factors had a lower risk of SLD, lower levels of gamma-glutamyl transferase, and lower fatty liver index scores, in participants with low and high genetic risks (P value for interaction 0.05). In relatively lean Chinese adults, individuals with fewer metabolic risk factors had a lower relative risk of
Curtir
Comentario
Compartilhar
